
Vaniam Group Names Richard Neave Chief Financial Officer
Mr. Neave brings 15+ years of CFO experience within mid- to large-sized medical communications and pharma services agencies
Stay abreast of the latest scientific developments and learn how the biopharma industry and medical community are finding new ways to improve decision-making and patient care. Here, we share our perspectives on a variety of topics in biopharma, healthcare, medical communications, and more.
Vaniam Group and oncology experts discuss the hottest topics from oncology and hematology conferences.
Mr. Neave brings 15+ years of CFO experience within mid- to large-sized medical communications and pharma services agencies
This marks the fourth consecutive year that Vaniam Group has qualified for this prestigious honor.
Patricia Mae Garcia Santos, MD, MS, receives annual Conquer Cancer-Women Leaders in Oncology “Women Who Conquer Cancer” Young Investigator Award and Tafadzwa L. Chaunzwa, MD, MHS, receives annual Conquer Cancer-Vaniam Group LLC Young Investigator Award, dedicated to Black, African, or African American cancer researchers
With 3 decades as a leading gynecologic oncologist, Dr. Coleman’s appointment reinforces Vaniam Group’s commitment to scientific excellence and advancing patient care.
Nineteen early-career clinical investigators to receive year-long mentorship and professional development program led by international thought leaders.
Ms. Franson will help biopharma clients design a phased approach to inform and execute clinical development plans, amplify awareness within clinician and patient communities, and form partnerships necessary to accelerate clinical trial completion.
After 8 years in leadership roles at Vaniam Group, Herzog’s appointment demonstrates agency’s continued focus on client service, operational excellence, and healthy growth.
At 9th annual WLO reception, Vaniam Group makes progress on $1.35 million endowment pledge, expands WLO to be a year-round community supporting female contributions in the field of oncology.
Dr Nze Is Second Annual Recipient of Grant Dedicated to Black, African, or African American Cancer Researchers; Will Research Barriers to Minority Participation in Lymphoma Clinical Trials.
Based on 2022 employee survey data, Vaniam Group scored among top 20 US health companies.
Vaniam Group Receives Recognition for Second Consecutive Year.
Vaniam Group Funds Annual Award Given to Black, African, or African American Cancer Researchers.
Vaniam Group to Match $100,000 for Young Investigator Award Endowment to Accelerate Future Oncology Research.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |